Medicofarma Biotech Sa Stock Current Valuation
| MDB Stock | 0.26 0.01 4.00% |
Valuation analysis of Medicofarma Biotech helps investors to measure Medicofarma Biotech's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Medicofarma Biotech's price fluctuation is out of control at this time. Calculation of the real value of Medicofarma Biotech is based on 3 months time horizon. Increasing Medicofarma Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Medicofarma stock is determined by what a typical buyer is willing to pay for full or partial control of Medicofarma Biotech SA. Since Medicofarma Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medicofarma Stock. However, Medicofarma Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.26 | Real 0.25 | Hype 0.26 | Naive 0.27 |
The intrinsic value of Medicofarma Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medicofarma Biotech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medicofarma Biotech SA helps investors to forecast how Medicofarma stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medicofarma Biotech more accurately as focusing exclusively on Medicofarma Biotech's fundamentals will not take into account other important factors: Medicofarma Biotech SA Company Current Valuation Analysis
Medicofarma Biotech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Medicofarma Biotech SA has a Current Valuation of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Biotechnology & Medical Research (which currently averages 0.0) industry. The current valuation for all Poland stocks is 100.0% higher than that of the company.
Medicofarma Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medicofarma Biotech's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medicofarma Biotech could also be used in its relative valuation, which is a method of valuing Medicofarma Biotech by comparing valuation metrics of similar companies.Medicofarma Biotech is currently under evaluation in current valuation category among its peers.
About Medicofarma Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medicofarma Biotech SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medicofarma Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medicofarma Biotech SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Medicofarma Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medicofarma Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicofarma Biotech will appreciate offsetting losses from the drop in the long position's value.Moving against Medicofarma Stock
The ability to find closely correlated positions to Medicofarma Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medicofarma Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medicofarma Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medicofarma Biotech SA to buy it.
The correlation of Medicofarma Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medicofarma Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medicofarma Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medicofarma Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Medicofarma Stock Analysis
When running Medicofarma Biotech's price analysis, check to measure Medicofarma Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicofarma Biotech is operating at the current time. Most of Medicofarma Biotech's value examination focuses on studying past and present price action to predict the probability of Medicofarma Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicofarma Biotech's price. Additionally, you may evaluate how the addition of Medicofarma Biotech to your portfolios can decrease your overall portfolio volatility.